ReviR Therapeutics Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

ReviR Therapeutics is a South San Francisco–based biotechnology research company that combines RNA biology with machine learning to develop medicines for human disease. Its platform aims to broaden the reachable target space beyond traditional protein targets, seeking to address disease targets historically considered undruggable. The company pursues therapies across cancer, rare genetic disorders, and infectious diseases, with initiatives tied to neurogenetic conditions such as spinal and bulbar muscular atrophy (SBMA) and Huntington’s disease. 

Its approach integrates human genetic data, functional genomics, and AI to decipher RNA motifs and understand the RNA life cycle at scale, informing the development of new therapies. In 2026, the company announced a strategic initiative to launch a precision medicine platform for Charcot–Marie–Tooth disease.

Sign up for free to view info

Company overview Employee directory